AVAI AVAI BIO, INC.
Services-Computer Processing & Data Preparation · OTC · SEC CIK 1740797 · Fiscal year ends 03/31
Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2027Q22026-09-30 | 2027Q12026-06-30 | 2026Q4*2026-03-31 | 2026Q32025-12-31 | 2026Q22025-09-30 | 2026Q12025-06-30 | 2025Q4*2025-03-31 | 2025Q32024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | — | — | — | — | — | — | — | — |
| R&D expense | — | — | -$8,804 | $0 | $23,804 | — | — | — |
| SG&A expense | $174,304 | $176,480 | $192,237 | $190,119 | $265,022 | $213,886 | -$175,003 | $259,974 |
| Operating income | -$253,240 | -$552,041 | -$255,177 | -$553,727 | -$453,016 | $487,589 | -$2.75M | $452,298 |
| Pretax income | — | — | — | — | — | — | — | -$452,298 |
| Net income | -$253,240 | -$552,041 | -$255,177 | -$553,727 | -$453,016 | $487,589 | $464,072 | -$452,298 |
| EBITDA | -$244,632 | -$546,797 | -$248,659 | -$547,210 | -$446,499 | $494,107 | -$2.73M | $471,815 |
| EPS (basic) | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | — | 0.00 |
| EPS (diluted) | — | — | — | — | — | — | — | — |
| Balance sheet | ||||||||
| Cash & equivalents | $121,948 | $83,586 | $23,145 | $50,402 | $91,995 | $10,062 | $81,053 | $3,070 |
| Current assets | $188,043 | $154,281 | $89,340 | $60,852 | $112,795 | $20,212 | $93,133 | $27,507 |
| PP&E, net | $1,500 | $1,500 | $1,500 | $1,500 | — | — | — | $1,500 |
| Intangibles | $150,290 | $158,898 | $105,542 | $112,060 | $118,577 | $125,094 | $131,612 | $147,379 |
| Total assets | $1.12M | $791,750 | $572,696 | $172,912 | $231,372 | $145,306 | $224,745 | $174,886 |
| Current liabilities | $4.53M | $4.01M | $3.39M | $2.97M | $2.53M | $2.14M | $1.79M | $2.31M |
| Short-term debt | — | — | $24,918 | $124,590 | $124,590 | $30,000 | $30,000 | $30,000 |
| Total liabilities | $4.53M | $4.01M | $3.39M | $2.97M | $2.53M | $2.14M | $1.79M | $2.31M |
| Shareholders' equity | -$3.42M | -$3.22M | -$2.82M | -$2.79M | -$2.30M | -$1.99M | -$1.56M | -$2.14M |
| Shares outstanding | 154.36M | 153.92M | 153.21M | 138.03M | 137.83M | 137.51M | 137.36M | 137.13M |
| Cash flow statement | ||||||||
| Operating cash flow | -$75,319 | -$414,258 | -$50,827 | -$347,127 | -$371,547 | -$240,343 | -$187,500 | -$134,353 |
| Investing cash flow | $0 | -$58,600 | — | — | — | — | — | — |
| Financing cash flow | $113,681 | $533,299 | $23,570 | $305,534 | $453,480 | $169,352 | $265,483 | $135,651 |
| Depreciation & amortization | $8,608 | $5,244 | $6,518 | $6,517 | $6,517 | $6,518 | $15,767 | $19,517 |
Free plan shows the latest 8 periods; Pro shows all 34 🔒
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.